RA Capital Management’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,649,057
| Closed | -$21.8M | – | 77 |
|
|
2025
Q1 | $21.8M | Buy |
3,649,057
+1,556,798
| +74% | +$9.29M | 0.36% | 40 |
|
|
2024
Q4 | $16.1M | Sell |
2,092,259
-1,092,452
| -34% | -$8.39M | 0.21% | 65 |
|
|
2024
Q3 | $32.5M | Sell |
3,184,711
-332,548
| -9% | -$3.4M | 0.37% | 47 |
|
|
2024
Q2 | $52.2M | Sell |
3,517,259
-900,000
| -20% | -$13.4M | 0.69% | 35 |
|
|
2024
Q1 | $60.3M | Hold |
4,417,259
| – | – | 0.77% | 37 |
|
|
2023
Q4 | $48.4M | Hold |
4,417,259
| – | – | 0.76% | 33 |
|
|
2023
Q3 | $48.4M | Hold |
4,417,259
| – | – | 0.95% | 30 |
|
|
2023
Q2 | $58.5M | Hold |
4,417,259
| – | – | 1.1% | 28 |
|
|
2023
Q1 | $60.1M | Hold |
4,417,259
| – | – | 1.36% | 26 |
|
|
2022
Q4 | $86.3M | Hold |
4,417,259
| – | – | 1.75% | 21 |
|
|
2022
Q3 | $84.1M | Hold |
4,417,259
| – | – | 1.8% | 17 |
|
|
2022
Q2 | $91M | Hold |
4,417,259
| – | – | 2.43% | 12 |
|
|
2022
Q1 | $142M | Hold |
4,417,259
| – | – | 3.1% | 5 |
|
|
2021
Q4 | $206M | Hold |
4,417,259
| – | – | 3.63% | 3 |
|
|
2021
Q3 | $119M | Hold |
4,417,259
| – | – | 1.65% | 20 |
|
|
2021
Q2 | $113M | Buy |
4,417,259
+1
| +0% | +$26 | 1.82% | 13 |
|
|
2021
Q1 | $151M | Hold |
4,417,258
| – | – | 2.28% | 10 |
|
|
2020
Q4 | $149M | Hold |
4,417,258
| – | – | 2.09% | 9 |
|
|
2020
Q3 | $109M | Buy |
+4,417,258
| New | +$109M | 1.99% | 15 |
|